KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Current Taxes (2021 - 2023)

Vir Biotechnology's Current Taxes history spans 3 years, with the latest figure at $15.3 million for Q1 2023.

  • For Q1 2023, Current Taxes fell 96.23% year-over-year to $15.3 million; the TTM value through Mar 2023 reached $15.3 million, down 96.23%, while the annual FY2022 figure was $15.2 million, 144.94% up from the prior year.
  • Current Taxes for Q1 2023 was $15.3 million at Vir Biotechnology, roughly flat from $15.2 million in the prior quarter.
  • Across five years, Current Taxes topped out at $404.4 million in Q1 2022 and bottomed at $6.2 million in Q4 2021.
  • The 3-year median for Current Taxes is $15.3 million (2023), against an average of $107.9 million.
  • The largest annual shift saw Current Taxes soared 144.94% in 2022 before it tumbled 96.23% in 2023.
  • A 3-year view of Current Taxes shows it stood at $6.2 million in 2021, then soared by 144.94% to $15.2 million in 2022, then rose by 0.16% to $15.3 million in 2023.
  • Per Business Quant, the three most recent readings for VIR's Current Taxes are $15.3 million (Q1 2023), $15.2 million (Q4 2022), and $98.2 million (Q3 2022).